| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |